- CTNM Dashboard
- Financials
- Filings
- Insider
- Shorts
-
Article
Morgan Stanley Initiates Coverage On Contineum Therapeutics with Overweight Rating, Announces Price Target of $25
Company Profile
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.